Reuters update on SNY’s planned divestitures says only the EU portion of SNY’s generic-drug business is being considered (as well as the Merial animal-health unit):
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.